These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 8378089

  • 1. SV40 T antigen abrogates p53-mediated transcriptional activity.
    Jiang D, Srinivasan A, Lozano G, Robbins PD.
    Oncogene; 1993 Oct; 8(10):2805-12. PubMed ID: 8378089
    [Abstract] [Full Text] [Related]

  • 2. The retinoblastoma susceptibility gene product regulates Myc-mediated transcription.
    Adnane J, Robbins PD.
    Oncogene; 1995 Jan 19; 10(2):381-7. PubMed ID: 7838535
    [Abstract] [Full Text] [Related]

  • 3. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
    Shivakumar CV, Das GC.
    Oncogene; 1996 Jul 18; 13(2):323-32. PubMed ID: 8710371
    [Abstract] [Full Text] [Related]

  • 4. Use of the two-hybrid system to identify the domain of p53 involved in oligomerization.
    Iwabuchi K, Li B, Bartel P, Fields S.
    Oncogene; 1993 Jun 18; 8(6):1693-6. PubMed ID: 8502489
    [Abstract] [Full Text] [Related]

  • 5. Wild-type p53 activates transcription in vitro.
    Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R, Prives C.
    Nature; 1992 Jul 02; 358(6381):83-6. PubMed ID: 1614538
    [Abstract] [Full Text] [Related]

  • 6. Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription.
    Miller CW, Chumakov A, Said J, Chen DL, Aslo A, Koeffler HP.
    Oncogene; 1993 Jul 02; 8(7):1815-24. PubMed ID: 8510927
    [Abstract] [Full Text] [Related]

  • 7. Mouse p53 blocks SV40 DNA replication in vitro and downregulates T antigen DNA helicase activity.
    Stürzbecher HW, Brain R, Maimets T, Addison C, Rudge K, Jenkins JR.
    Oncogene; 1988 Oct 02; 3(4):405-13. PubMed ID: 2856250
    [Abstract] [Full Text] [Related]

  • 8. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
    Uramoto H, Hackzell A, Wetterskog D, Ballági A, Izumi H, Funa K.
    J Cell Sci; 2004 Aug 01; 117(Pt 17):3855-65. PubMed ID: 15265983
    [Abstract] [Full Text] [Related]

  • 9. Abrogation of p53-mediated transactivation by SV40 large T antigen.
    Segawa K, Minowa A, Sugasawa K, Takano T, Hanaoka F.
    Oncogene; 1993 Mar 01; 8(3):543-8. PubMed ID: 8382354
    [Abstract] [Full Text] [Related]

  • 10. Analysis of p53 transactivation through high-affinity binding sites.
    Chumakov AM, Miller CW, Chen DL, Koeffler HP.
    Oncogene; 1993 Nov 01; 8(11):3005-11. PubMed ID: 8414502
    [Abstract] [Full Text] [Related]

  • 11. A potential transcriptional activation element in the p53 protein.
    O'Rourke RW, Miller CW, Kato GJ, Simon KJ, Chen DL, Dang CV, Koeffler HP.
    Oncogene; 1990 Dec 01; 5(12):1829-32. PubMed ID: 2284102
    [Abstract] [Full Text] [Related]

  • 12. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
    Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H, Inoue M.
    Clin Cancer Res; 2000 Apr 01; 6(4):1239-47. PubMed ID: 10778946
    [Abstract] [Full Text] [Related]

  • 13. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice.
    Gordon J, Del Valle L, Otte J, Khalili K.
    Oncogene; 2000 Oct 05; 19(42):4840-6. PubMed ID: 11039901
    [Abstract] [Full Text] [Related]

  • 14. p53 and SV40 T antigen bind to the same region overlapping the conserved domain of the TATA-binding protein.
    Martin DW, Subler MA, Muñoz RM, Brown DR, Deb SP, Deb S.
    Biochem Biophys Res Commun; 1993 Aug 31; 195(1):428-34. PubMed ID: 8395834
    [Abstract] [Full Text] [Related]

  • 15. A 47-amino-acid fragment of SV40 T antigen represses transcription from human GSTalpha promoters.
    Sompayrac L, Jane S, Lörper M, Sies H.
    Virology; 1998 Sep 30; 249(2):275-85. PubMed ID: 9791019
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of p53-dependent gene activation by the transcriptional coactivator Zac1.
    Huang SM, Schönthal AH, Stallcup MR.
    Oncogene; 2001 Apr 19; 20(17):2134-43. PubMed ID: 11360197
    [Abstract] [Full Text] [Related]

  • 17. The three transforming regions of SV40 T antigen are required for immortalization of primary mouse embryo fibroblasts.
    Conzen SD, Cole CN.
    Oncogene; 1995 Dec 07; 11(11):2295-302. PubMed ID: 8570180
    [Abstract] [Full Text] [Related]

  • 18. HPV-18 E6 inhibits p53 DNA binding activity regardless of the oligomeric state of p53 or the exact p53 recognition sequence.
    Thomas M, Massimi P, Banks L.
    Oncogene; 1996 Aug 01; 13(3):471-80. PubMed ID: 8760288
    [Abstract] [Full Text] [Related]

  • 19. Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal transduction pathways.
    Kühnel F, Zender L, Wirth T, Schulte B, Trautwein C, Manns M, Kubicka S.
    Cancer Gene Ther; 2004 Jan 01; 11(1):28-40. PubMed ID: 14681724
    [Abstract] [Full Text] [Related]

  • 20. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.
    Fukuma T, Enomoto N, Marumo F, Sato C.
    Hepatology; 1998 Oct 01; 28(4):1147-53. PubMed ID: 9755255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.